kt 5823 has been researched along with tranexamic acid in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (tranexamic acid) | Trials (tranexamic acid) | Recent Studies (post-2010) (tranexamic acid) |
---|---|---|---|---|---|
317 | 0 | 59 | 5,052 | 1,129 | 3,390 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rieks, M; Simmet, T; Syrovets, T; Tippler, B | 1 |
1 other study(ies) available for kt 5823 and tranexamic acid
Article | Year |
---|---|
Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway.
Topics: Alkaloids; Aminoquinolines; Benzophenanthridines; Binding Sites; Carbazoles; Chemotactic Factors; Chemotaxis; Cyclic GMP; Enzyme Inhibitors; Fibrinolysin; Glyceryl Ethers; Guanylate Cyclase; Humans; Indoles; Lysine; Male; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Organ Specificity; Pertussis Toxin; Phenanthridines; Plasminogen; Protein Kinase C; Signal Transduction; Thionucleotides; Tranexamic Acid; Urokinase-Type Plasminogen Activator; Virulence Factors, Bordetella | 1997 |